Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAPK6 |
| Upstream (Parents) |
|---|
| (<<) ADAM10 → MAPK6 |
| (<<) BLNK → MAPK6 |
| (<<) BZW1 → MAPK6 |
| (<<) GRN → MAPK6 |
| (<<) GRPEL1 → MAPK6 |
| (<<) HMGA2 → MAPK6 |
| (<<) MAPK1 → MAPK6 |
| (<<) MCL1 → MAPK6 |
| (<<) PDIA3 → MAPK6 |
| (<<) PPIB → MAPK6 |
| (<<) PYGL → MAPK6 |
| (<<) SH3TC1 → MAPK6 |
| (<<) SMAD5 → MAPK6 |
| Downstream (Children) |
|---|
| MAPK6 → CCND3 (>>) |
| MAPK6 → CRK (>>) |
| MAPK6 → DUSP5 (>>) |
| MAPK6 → HLA-DOA (>>) |
| MAPK6 → IL1F5 (>>) |
| MAPK6 → MEX3D (>>) |
| MAPK6 → PAK4 (>>) |
| MAPK6 → PIK3R5 (>>) |
| MAPK6 → PLCH2 (>>) |
| MAPK6 → SPINK1 (>>) |
| MAPK6 → ZNF750 (>>) |
